Clinical trials

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07770685
Recruiting
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
Phase 1/2 · United States · 1 site
Registry update: 22 Oct 2026
NCT07633171
Recruiting
Multimodal Glucose Prediction in Type 2 Diabetes
Not applicable · United States · 1 site
Registry update: 8 Oct 2026
NCT07386496
Recruiting
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
Not applicable · Hong Kong · 1 site
Registry update: 27 Oct 2026
NCT07892573
Recruiting
Becotatug Vedotin Plus Anti-PD-1 and S-1 in Patients With EGFR-Positive Advanced Pancreatic Cancer Who Have Failed at Least One Line of Standard Therapy
Not applicable · China · 1 site
Registry update: 23 Oct 2026
2026-526336-39-00
Recruiting
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
Phase 3 · Czechia, Germany, Greece, Poland · 43 sites
Registry update: 13 Oct 2026
NCT07899502
Recruiting
REAL-MS: Observational Database Study of AHSCT and MS Therapies
Not applicable · United Kingdom · 3 sites
Registry update: 27 Oct 2026
NCT07775287
Recruiting
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
Phase 3 · Puerto Rico, United States · 5 sites
Registry update: 3 Nov 2026
NCT07871864
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Phase 3 · Denmark, Spain, Finland, France, Italy, Netherlands, Poland, Sweden · 77 sites
Registry update: 26 Oct 2026
NCT06741241
Recruiting
Effectiveness of an eHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women
Not applicable · United States · 1 site
Registry update: 14 Oct 2026
NCT07743164
Recruiting
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
Phase 3 · Israel, Taiwan, United States · 6 sites
Registry update: 30 Oct 2026
NCT07822399
Recruiting
A Study of MGC030 in Participants With Advanced Solid Tumors
Phase 1 · United States · 1 site
Registry update: 30 Oct 2026
NCT07412704
Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Phase 1/2 · Belgium, Brazil, Switzerland, China, Germany, Spain, Italy, Mexico, Poland, Ukraine, United States · 39 sites
Registry update: 23 Oct 2026
NCT07323316
Recruiting
Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
Not applicable · Germany, Denmark, Spain, France, Italy · 20 sites
Registry update: 5 Nov 2026
NCT07911280
Recruiting
A Phase II, Trial of Neoadjuvant Trastuzumab + Durvalumab + FLOT Targeted Immunochemotherapy
Phase 2 · South Korea · 1 site
Registry update: 2 Nov 2026
2026-526670-16-00
Recruiting
Drug-drug interaction study of midazolam and brensocatib
Phase 1 · Netherlands · 1 site
Registry update: 28 Sept 2026
NCT07829185
Recruiting
Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer
Phase 1 · United States · 1 site
Registry update: 6 Nov 2026
NCT07566091
Recruiting
Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers
Not applicable · South Korea · 1 site
Registry update: 7 Oct 2026
NCT07587658
Recruiting
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
Phase 4 · Belgium, Spain, Italy, United States · 14 sites
Registry update: 16 Oct 2026
NCT07322341
Recruiting
SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
Phase 2 · United States · 1 site
Registry update: 13 Oct 2026
2025-524722-17-00
Recruiting
Short and long-term Hemodynamic and Physiological Effects of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Phase 4 · Sweden · 2 sites
Registry update: 26 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.